Tatyana Prigozhina

Title: Tatyana Prigozhina: Innovator in Hematopoietic Treatments

Introduction

Tatyana Prigozhina is a notable inventor based in Rehovot, Israel. She has made significant contributions to the field of hematopoietic disorders through her innovative research and patented methods. With a total of 3 patents, her work focuses on enhancing treatment options for patients with various hematopoietic conditions.

Latest Patents

One of her latest patents involves methods of treatment for hematopoietic disorders. This patent describes a composition that includes bone marrow cells (BMC) and demineralized bone matrix (DBM) and/or mineralized bone matrix (MBM). The composition is particularly useful for bone marrow transplantation, either into the bone marrow cavity or extraskeletal sites. It aims to restore and enhance the formation of the hematopoietic microenvironment originating from the transplanted BMC. This invention is beneficial for treating conditions such as stem cell deficiencies, genetic disorders affecting stem cells, and both malignant and non-malignant hematopoietic disorders. Additionally, it provides methods for inducing graft tolerance and preventing graft-versus-host disease.

Another significant patent by Prigozhina features a non-myeloablative tolerogenic treatment method. This method induces donor-specific tolerance in a host by administering an immunosuppressive agent in a non-myeloablative regimen. The process involves infusing donor antigens into the host and eliminating host T lymphocytes that respond to these antigens. This innovative approach enhances the efficacy of donor-derived materials in transplantation.

Career Highlights

Throughout her career, Tatyana Prigozhina has worked with Hadasit Medical Research Services and Development Ltd. Her research has significantly impacted the field of hematology and transplantation, showcasing her dedication to improving patient outcomes.

Collaborations

Prigozhina has collaborated with esteemed colleagues such as Shimon Slavin and Olga Gurevitch. These partnerships have further enriched her research and contributed to the advancement of her innovative treatments.

Conclusion

Tatyana Prigozhina's work in the field of hematopoietic disorders exemplifies her commitment to innovation and patient care. Her patents reflect a deep understanding of complex medical challenges and a drive to develop effective solutions.